DDS vs. CRVS

Last updated Jun 13, 2026

DDS (Dillard's, Inc.) and CRVS (Corvus Pharmaceuticals, Inc.) are both stocks. DDS operates in Department Stores (Consumer Cyclical), while CRVS operates in Biotechnology (Healthcare). Over the past 10 years, DDS returned 30.59%/yr vs 0.06%/yr for CRVS. At a 0.14 correlation, their price movements are largely independent.

Performance

DDS vs. CRVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dillard's, Inc. (DDS) and Corvus Pharmaceuticals, Inc. (CRVS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, DDS achieves a 0.66% return, which is significantly lower than CRVS's 54.94% return. Over the past 10 years, DDS has outperformed CRVS with an annualized return of 30.59%, while CRVS has yielded a comparatively lower 0.06% annualized return.

DDS

• 1D: -0.70%
• 1M: 14.47%
• YTD: 0.66%
• 6M: -10.45%
• 1Y: 58.44%
• 3Y*: 27.17%
• 5Y*: 35.97%
• 10Y*: 30.59%

CRVS

• 1D: 2.84%
• 1M: -24.68%
• YTD: 54.94%
• 6M: 42.53%
• 1Y: 181.37%
• 3Y*: 53.32%
• 5Y*: 33.63%
• 10Y*: 0.06%

*Multi-year figures are annualized to reflect compound growth (CAGR)

DDS vs. CRVS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
DDS Dillard's, Inc.	0.66%	46.81%	13.47%	32.05%	38.66%	306.41%	-12.71%	22.76%	0.97%	-3.63%
CRVS Corvus Pharmaceuticals, Inc.	54.94%	43.93%	203.98%	107.06%	-64.73%	-32.30%	-34.56%	48.23%	-64.58%	-27.55%

Correlation

The correlation between DDS and CRVS is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.13
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (10Y) Calculated over the trailing 10-year period	0.14
Correlation (All Time) Calculated using the full available price history since Mar 23, 2016	0.14

Fundamentals

Market Cap DDS : $9.52B CRVS : $1.07B
EPS DDS : $42.07 CRVS : -$0.53
PB Ratio DDS : 3.66 CRVS : 4.46
Total Revenue (TTM) DDS : $6.58B CRVS : $0.00
Gross Profit (TTM) DDS : $1.82B CRVS : -$26.00K
EBITDA (TTM) DDS : $985.80M CRVS : -$47.43M

Return for Risk

DDS vs. CRVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DDS

DDS Risk / Return Rank: 80
DDS Sharpe Ratio Rank: 83
DDS Sortino Ratio Rank: 78
DDS Omega Ratio Rank: 77
DDS Calmar Ratio Rank: 80
DDS Martin Ratio Rank: 79

CRVS

CRVS Risk / Return Rank: 86
CRVS Sharpe Ratio Rank: 73
CRVS Sortino Ratio Rank: 96
CRVS Omega Ratio Rank: 93
CRVS Calmar Ratio Rank: 85
CRVS Martin Ratio Rank: 83

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DDS vs. CRVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dillard's, Inc. (DDS) and Corvus Pharmaceuticals, Inc. (CRVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	DDS	CRVS	Difference
Sharpe ratio: Return per unit of total volatility	1.48	1.01	+0.47
Sortino ratio: Return per unit of downside risk	2.07	4.24	-2.17
Omega ratio: Gain probability vs. loss probability	1.27	1.48	-0.21
Calmar ratio: Return relative to maximum drawdown	2.42	3.23	-0.81
Martin ratio: Return relative to average drawdown	5.60	7.03	-1.43

DDS vs. CRVS - Sharpe Ratio Comparison

The current DDS Sharpe Ratio is 1.48, which is higher than the CRVS Sharpe Ratio of 1.01. The chart below compares the historical Sharpe Ratios of DDS and CRVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

DDS vs. CRVS - Drawdown Comparison

The maximum DDS drawdown since its inception was -93.62%, roughly equal to the maximum CRVS drawdown of -96.97%. Use the drawdown chart below to compare losses from any high point for DDS and CRVS.

Drawdown Indicators

	DDS	CRVS	Difference
Max Drawdown Largest peak-to-trough decline	-93.62%	-96.97%	+3.35%
Max Drawdown (1Y) Largest decline over 1 year	-24.27%	-56.43%	+32.16%
Max Drawdown (3Y) Largest decline over 3 years	-42.02%	-70.50%	+28.48%
Max Drawdown (5Y) Largest decline over 5 years	-49.71%	-92.40%	+42.69%
Max Drawdown (10Y) Largest decline over 10 years	-76.57%	-96.97%	+20.40%
Current Drawdown Current decline from peak	-12.84%	-53.25%	+40.41%
Average Drawdown Average peak-to-trough decline	-35.61%	-69.28%	+33.67%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.47%	25.91%	-15.44%

Volatility

DDS vs. CRVS - Volatility Comparison

The current volatility for Dillard's, Inc. (DDS) is 10.15%, while Corvus Pharmaceuticals, Inc. (CRVS) has a volatility of 23.12%. This indicates that DDS experiences smaller price fluctuations and is considered to be less risky than CRVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DDS	CRVS	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.15%	23.12%	-12.97%
Volatility (6M) Calculated over the trailing 6-month period	27.84%	111.88%	-84.04%
Volatility (1Y) Calculated over the trailing 1-year period	39.57%	180.64%	-141.07%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	50.28%	131.02%	-80.74%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	59.53%	111.13%	-51.60%

Dividends

DDS vs. CRVS - Dividend Comparison

DDS's dividend yield for the trailing twelve months is around 5.11%, while CRVS has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CRVS Corvus Pharmaceuticals, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DDS Dillard's, Inc.	5.11%	5.13%	6.02%	5.18%	4.89%	6.41%	0.95%	0.68%	0.66%	0.57%	0.45%	0.40%

Financials

Frequently Asked Questions

Can I hold both DDS and CRVS in my portfolio?

DDS and CRVS have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, DDS or CRVS?

CRVS has higher volatility (23.12%) compared to DDS (10.15%). In terms of maximum drawdown, DDS dropped -93.62% vs CRVS's -96.97%.

Which has better risk-adjusted returns?

DDS currently has the higher Sharpe Ratio (1.48 vs 1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.